Provided by Tiger Trade Technology Pte. Ltd.

GRACE THERAPEUTICS INC

2.20
+0.06002.80%
Volume:75.91K
Turnover:167.00K
Market Cap:46.28M
PE:-1.83
High:2.23
Open:2.15
Low:2.15
Close:2.14
52wk High:5.18
52wk Low:1.79
Shares:21.04M
Float Shares:15.51M
Volume Ratio:0.47
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2003
EPS(LYR):-0.7916
ROE:-36.19%
ROA:-10.81%
PB:0.96
PE(LYR):-2.78

Loading ...

Company Profile

Company Name:
GRACE THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
2002
Employees:
5
Office Location:
103 Carnegie Center,Suite 300,Princeton,New Jersey,United States
Zip Code:
08540
Fax:
- -
Introduction:
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Directors

Name
Position
Prashant Kohli
Chief Executive Officer and Director
A. Brian Davis
Independent Director
Edward Neugeboren
Independent Director
S. George Kottayil
Independent Director
Vimal Kavuru
Chair of the Board and Independent Director

Shareholders

Name
Position
Prashant Kohli
Chief Executive Officer and Director
Amresh Kumar
Vice President, Program Management
R. Loch Macdonald
Chief Medical Officer
Robert J. DelAversano
Vice President, Finance,Principal Accounting Officer and Principal Financial Officer